Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An improved algorithm for determining HIV type 1 subtypes in a primary laboratory in Uganda.

P Kaleebu1, D Yirrell, N French

  • 1Medical Research Council Programme on AIDS in Uganda, Uganda Virus Research Institute, Entebbe. mrc@starcom.co.ug

AIDS Research and Human Retroviruses
|May 3, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standards, equality and safety in Mohs micrographic surgery for patients living with HIV.

Clinical and experimental dermatology·2020
Same author

Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda.

BMC health services research·2015
Same author

Burden of influenza B virus infections in Scotland in 2012/13 and epidemiological investigations between 2000 and 2012.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Same author

Field study of dried blood spot specimens for HIV-1 drug resistance genotyping.

Journal of clinical microbiology·2014
Same author

British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011.

HIV medicine·2011
Same author

Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2011

This study developed a cost-effective algorithm for HIV-1 subtyping in Uganda. The new method combines peptide enzyme immunoassays (PEIA) and heteroduplex mobility assay (HMA) for accurate identification of subtypes A and D.

Area of Science:

  • Virology
  • Epidemiology
  • Biotechnology

Background:

  • Accurate human immunodeficiency virus type 1 (HIV-1) subtyping is crucial for epidemiological studies.
  • Existing subtyping methods can be costly and complex for large-scale cohort studies.

Purpose of the Study:

  • To develop a simple, economical, and efficient algorithm for HIV-1 subtyping in a Ugandan epidemiological cohort.
  • To evaluate the performance of peptide enzyme immunoassay (PEIA) and heteroduplex mobility assay (HMA) against DNA sequencing.

Main Methods:

  • A pilot study compared PEIA (V3 and gp41 regions) and HMA with DNA sequencing for HIV-1 subtyping.
  • 146 samples were analyzed, with 115 successfully sequenced as the gold standard.
  • An algorithm was developed using PEIA, followed by HMA, and DNA sequencing for unclassifiable samples.

Related Experiment Videos

Main Results:

  • Heteroduplex mobility assay (HMA) correctly identified 83% of samples.
  • Combined V3/gp41 PEIA showed improved accuracy (78%) and reduced misidentification compared to V3 PEIA alone (76%).
  • The proposed algorithm achieved 95% accuracy with significant cost savings on consumables.

Conclusions:

  • A novel algorithm combining PEIA and HMA offers a cost-effective and accurate method for HIV-1 subtyping.
  • This approach is suitable for large epidemiological studies, particularly in regions with predominant HIV-1 subtypes A and D.
  • The algorithm enhances the efficiency of HIV-1 subtyping in resource-limited settings.